Recap: Syros Pharmaceuticals Q4 Earnings

Syros Pharmaceuticals NASDAQ:SYRS reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Syros Pharmaceuticals beat estimated earnings by 19.15%, reporting an EPS of $-0.38 versus an estimate of $-0.47.

Revenue was up $2.10 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 3.17% increase in the share price the next day.

Here's a look at Syros Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.